Idex Corporation · NYSE:IEX

Idex — Q2 2019 Earnings Presentation

9 slides from Idex's earnings presentation, Jul 26, 2019

  1. Slide 1: Second Quarter 2019 Earnings

    Second Quarter 2019 Earnings July 26, 2019 IDEX Proprietary & Confidential

  2. Slide 2: Agenda

    AGENDA • IDEX’s Overview and Outlook • Q2 Financial Performance • Segment Performance • Fluid & Metering Technologies • Health & Science Technologies • Fire & Safety / Diversified Products • 2019 Guidance Summary • Q&A Brand names shown in this presentation are registered trademarks of IDEX Corporat

  3. Slide 3: Replay Information

    Replay Information • Dial toll–free: 877.660.6853 • International: 201.612.7415 • Conference ID: #13684163 • Log on to: www.idexcorp.com Brand names shown in this presentation are registered trademarks of IDEX Corporation and/or its subsidiaries IDEX Proprietary & Confidential 2

  4. Slide 4: Cautionary Statement Under the Private Securities Litigation Reform Act; Non-GAAP Measures

    Cautionary Statement Under the Private Securities Litigation Reform Act; Non-GAAP Measures This presentation and discussion will include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. These statements may relate to, among other thin

  5. Slide 5: IDEX Q2 Financial Performance

    IDEX Q2 Financial Performance (Dollars in millions, excl. EPS) Sales EPS* 7% increase Organic: 3% increase $1.50 $1.40 $634 $642 $1.50 $700 $1.00 $500 $0.50 $300 $0.00 Q2 Q2 2018 2019 2018 2019 Operating Margin* Free Cash Flow 90 bps increase 8% increase $118 24.5% $110 23.6% 26.0% $125 24.0% 22.0%

  6. Slide 6: Fluid & Metering Technologies

    Fluid & Metering Technologies (Dollars in millions) Orders Sales Operating Margin* Organic: Flat Organic: 3% increase 100 bps increase $246 $243 $246 $242 30.5% $300 29.5% $300 32.0% $200 30.0% $200 28.0% $100 $100 26.0% $0 $0 24.0% Q2 Q2 Q2 2018 2019 2018 2019 2018 2019 Q2 Sales Mix: Organic 3% Q2

  7. Slide 7: Health & Science Technologies

    Health & Science Technologies (Dollars in millions) Orders Sales Operating Margin* Organic: Flat Organic: 3% increase 100 bps increase $222 $219 $227 $232 24.6% $250 $250 26.0% 23.6% $200 $200 24.0% $150 $150 22.0% $100 $100 20.0% Q2 Q2 Q2 2018 2019 2018 2019 2018 2019 Q2 Sales Mix: Organic 3% Q2 Hi

  8. Slide 8: Fire & Safety / Diversified Products

    Fire & Safety / Diversified Products (Dollars in millions) Orders Sales Operating Margin* Organic: Flat Organic: 3% increase 100 bps decrease 28.1% $172 $164 $164 $168 30.0% 27.1% $200 $200 $150 $150 25.0% $100 $100 20.0% $50 $50 Q2 Q2 Q2 2018 2019 2018 2019 2018 2019 Q2 Sales Mix: Organic 3% Q2 Hig

  9. Slide 9: 2019 Guidance Summary

    2019 Guidance Summary Q3 2019 – EPS estimate range: $1.45 – $1.47 – Organic revenue growth: ~3% – Operating margin: ~24.0% – Tax rate: ~22.5% – FX impact: ~1.0% topline headwind based on June 30, 2019 FX rates – Corporate costs: ~$20 million FY 2019 – EPS estimate range: $5.78 – $5.85 – Organic reve

IDEX — Q2 2019 Earnings Presentation on 6ix